Christopher Paul Gibson

US Patent:

20230126130, Apr 27, 2023

Filed:

Oct 22, 2021

Appl. No.:

17/452009

Inventors:

- Foster City CA, US
Christopher James Gibson - Belmont CA, US

International Classification:

G01C 21/36
G08G 1/0968
G06K 9/00

Abstract:

The present disclosure is related to generating map data explicitly indicating a total drivable surface, which may include multiple types of drivable surfaces. For instance, a given portion of a map may include map data indicating a combination of various drivable surfaces, such as road segments, lane properties, intersections, parking areas, shoulders, driveways, etc. Examples of the present disclosure join these different types of drivable surfaces into combined map data that explicitly indicates a total drivable surface, such as a perimeter boundary indicating or representing a transition from a drivable surface to a non-drivable surface. The map data indicating the total drivable surface may be searched to determine information related to a drivable surface boundary, such as location and type. This boundary information may be used in various contexts, such as when planning a trajectory or remotely controlling a vehicle.

US Patent:

20230127185, Apr 27, 2023

Filed:

Oct 22, 2021

Appl. No.:

17/452006

Inventors:

- Foster City CA, US
Christopher James Gibson - Belmont CA, US

International Classification:

B60W 60/00
G01C 21/00

Abstract:

The present disclosure is related to generating map data explicitly indicating a total drivable surface, which may include multiple types of drivable surfaces. For instance, a given portion of a map may include map data indicating a combination of various drivable surfaces, such as road segments, lane properties, intersections, parking areas, shoulders, driveways, etc. Examples of the present disclosure join these different types of drivable surfaces into combined map data that explicitly indicates a total drivable surface, such as a perimeter boundary indicating or representing a transition from a drivable surface to a non-drivable surface. The map data indicating the total drivable surface may be searched to determine information related to a drivable surface boundary, such as location and type. This boundary information may be used in various contexts, such as when planning a trajectory or remotely controlling a vehicle.

US Patent:

20230077909, Mar 16, 2023

Filed:

Sep 15, 2021

Appl. No.:

17/476259

Inventors:

- Foster City CA, US
Christopher James Gibson - Belmont CA, US
Christopher Patton - Daly City CA, US
Rohit Wadhwa - Fremont CA, US

International Classification:

B60W 60/00
G01C 21/00
G06N 20/00

Abstract:

Techniques for generating and validating map data that may be used by a vehicle to traverse an environment are described herein. The techniques may include receiving sensor data representing an environment and receiving map data indicating a traffic control annotation. The traffic control annotation may be associated, as projected data, with the sensor data based at least in part on a position or orientation associated with a vehicle. Based at least in part on the association, the map data may be updated and sent to a fleet of vehicles. Additionally, based at least in part on the association the vehicle may determine to trust the sensor data more than the map data while traversing the environment.

US Patent:

20180258171, Sep 13, 2018

Filed:

Sep 20, 2016

Appl. No.:

15/761262

Inventors:

- Rahway NJ, US
Linda Liang - Mountain View CA, US
Michael Eric Bigler - Redwood City CA, US
Christopher John Gibson - Kennett Square PA, US

Assignee:

Merck Sharp & Dohme Corp. - Rahway NJ

International Classification:

C07K 16/28
G01N 33/574
A61P 35/00

Abstract:

The present disclosure provides antibodies and antigen binding fragments thereof including, but not limited to, monoclonal antibodies that specifically bind to human programmed death ligand 2 (PD-L2). The invention further provides nucleic acids encoding the antibodies and antigen binding fragments of the invention and host cells transformed therewith. The antibodies and antigen binding proteins of the invention are useful in methods for the immunohistochemical detection of human PD-L2 expression in tissue samples.